Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07028216 · ClinicalTrials.gov registry record · NA

Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method

A NA study of Major Depressive Disorder and Anxiety Disorders, sponsored by Georgetown University.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT07028216 is a NA study of Major Depressive Disorder and Anxiety Disorders that is actively recruiting participants, run by Georgetown University. The registered enrollment target is 80 participants, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07028216, a NA study of Major Depressive Disorder and Anxiety Disorders, is actively recruiting participants, sponsored by Georgetown University.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The study will compare the delivery of an 8-week Mindful Self-Compassion training, in-person against video-conference, on anxiety and depression symptom severity in patients with diagnosed anxiety disorders (generalized anxiety disorder, social anxiety disorder, and panic disorder) or major depressive disorder or dysthymia.

Interventions

  • BEHAVIORAL Mindful Self-Compassion

Study Locations (1)

District of Columbia

  • Georgetown University Medical Center - Washington D.C.

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2025-06
Est. Completion 2026-08-31
Phase NA

Sponsor

Georgetown University

227 total trials

What the Registry Record Tells You About NCT07028216

The ClinicalTrials.gov registry entry for NCT07028216 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (79% lower). The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Major Depressive Disorder appearing as the primary indexed condition, and to 1 intervention - of which Mindful Self-Compassion is the first listed.

NCT07028216 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.

Frequently Asked Questions

What is clinical trial NCT07028216 about?

NCT07028216 is a clinical study titled "Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method". The study will compare the delivery of an 8-week Mindful Self-Compassion training, in-person against video-conference, on anxiety and depression symptom severity in patients with diagnosed anxiety disorders (generalized anxiety disorder, social anxiety disorder, and panic disorder) or major depressi...

What is the current status of trial NCT07028216?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-06. Estimated completion is 2026-08-31.

What conditions does trial NCT07028216 study?

This clinical trial studies the following conditions: Major Depressive Disorder, Anxiety Disorders, Generalized Anxiety Disorder, Social Anxiety Disorder, Panic Disorder.

What interventions are being tested in trial NCT07028216?

The interventions under investigation include: Mindful Self-Compassion (BEHAVIORAL).

Who is sponsoring clinical trial NCT07028216?

This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07028216 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.